Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation

Overexpression of heterogeneous nuclear ribonucleoproteins (hnRNPs) A2 and B1 has been observed in a variety of tumour types, however, it is unknown whether this dysregulation is a consequence of, or a driving force for, unregulated cell proliferation. We have shown that the levels of hnRNPs A1, A2 and B1, but not A3, are modulated during the cell cycle of Colo16 squamous carcinoma cells and HaCaT immortalized keratinocytes, suggesting that A1, A2 and B1 are needed at particular cell cycle stages. However, the levels of hnRNP A1, A2 and B1 mRNAs were constant, indicating that regulation of protein levels was controlled at the level of translation. RNAi suppression of hnRNP A1 or A3 alone did not affect the proliferation of Colo16 cells but the proliferation rate was significantly reduced when both were suppressed simultaneously, or when either was suppressed together with hnRNP A2. Reducing hnRNP A2 expression in Colo16 and HaCaT cells by RNAi led to a non-apoptotic-related decrease in cell proliferation, reinforcing the view that this protein is required for cell proliferation. Suppression of hnRNP A2 in Colo16 cells was associated with increased p21 levels but p53 levels remained unchanged. In addition, expression of BRCA1 was downregulated, at both mRNA and protein levels. The observed effects of hnRNP A2 and its isoforms on cell proliferation and their correlation with BRCA1 and p21 expression suggest that these hnRNP proteins play a role in cell proliferation.

[1]  Johanne Toutant,et al.  Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines. , 2003, Cancer research.

[2]  S. Vicent,et al.  Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. , 2003, Lung cancer.

[3]  A. Sakurada,et al.  hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. , 2003, Lung cancer.

[4]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[5]  K. Ohshima,et al.  Overexpression of heterogeneous nuclear ribonucleoprotein B1 in lymphoproliferative disorders: high expression in cells of follicular center origin. , 2002, International journal of oncology.

[6]  B. Lyn‐Cook,et al.  Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. , 2002, Cancer letters.

[7]  T. Rudel,et al.  Prediction of translocation and cleavage of heterogeneous ribonuclear proteins and Rho guanine nucleotide dissociation inhibitor 2 during apoptosis by subcellular proteome analysis , 2002, Proteomics.

[8]  M. Mann,et al.  Large-scale Proteomic Analysis of the Human Spliceosome References , 2006 .

[9]  C. Ball,et al.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.

[10]  Trent P Munro,et al.  Heterogeneous Nuclear Ribonucleoprotein A3, a Novel RNA Trafficking Response Element-binding Protein* , 2002, The Journal of Biological Chemistry.

[11]  T. Bergman,et al.  Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins. , 2002, Nucleic acids research.

[12]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[13]  G. Dreyfuss,et al.  Messenger-RNA-binding proteins and the messages they carry , 2002, Nature Reviews Molecular Cell Biology.

[14]  M. Tockman,et al.  Lung cancer evolution to preinvasive management. , 2002, Clinics in chest medicine.

[15]  M. Tockman,et al.  Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. , 2001, Lung cancer.

[16]  C. Prange,et al.  Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype. , 2001, Cancer Letters.

[17]  T. Rudel,et al.  Predominant Identification of RNA-binding Proteins in Fas-induced Apoptosis by Proteome Analysis* , 2001, The Journal of Biological Chemistry.

[18]  J. Mulshine,et al.  Differential Expression of the Early Lung Cancer Detection Marker, Heterogeneous Nuclear Ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in Normal Breast and Neoplastic Breast Cancer , 2001, Breast Cancer Research and Treatment.

[19]  H. Fujiki,et al.  Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia. , 2001, Cancer research.

[20]  H. Satoh,et al.  Expression of hnRNP B1 in four major histological types of lung cancers. , 2001, Anticancer research.

[21]  H. Satoh,et al.  Characterization of hnRNP A2 and B1 using monoclonal antibodies: intracellular distribution and metabolism through cell cycle. , 2001, Immunology letters.

[22]  A. Shyu,et al.  The Double Lives of Shuttling mRNA Binding Proteins , 2000, Cell.

[23]  S. Dupuis,et al.  Heterogeneous Nuclear Ribonucleoprotein A1 and UP1 Protect Mammalian Telomeric Repeats and Modulate Telomere Replication in Vitro * , 2000, The Journal of Biological Chemistry.

[24]  H. Fujiki,et al.  Significance of Heterogeneous Nuclear Ribonucleoprotein B1 as a New Early Detection Marker for Oral Squamous Cell Carcinoma , 1999, Japanese journal of cancer research : Gann.

[25]  W. Prime,et al.  Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  A. Sewing,et al.  Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1 , 1999, The EMBO journal.

[27]  P. Parsons,et al.  Critical targets of protein kinase C in differentiation of tumour cells. , 1999, Biochemical pharmacology.

[28]  M. Swanson,et al.  hnRNP complexes: composition, structure, and function. , 1999, Current opinion in cell biology.

[29]  H. Fujiki,et al.  Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. , 1999, Cancer research.

[30]  G. Dreyfuss,et al.  Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms. , 1999, Experimental cell research.

[31]  B. Dörken,et al.  Identification of Apoptosis-associated Proteins in a Human Burkitt Lymphoma Cell Line , 1998, The Journal of Biological Chemistry.

[32]  J. Mulshine,et al.  Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development. , 1998, American journal of respiratory cell and molecular biology.

[33]  S. Dupuis,et al.  Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase , 1998, Nature Genetics.

[34]  K. Hoek,et al.  hnRNP A2 selectively binds the cytoplasmic transport sequence of myelin basic protein mRNA. , 1998, Biochemistry.

[35]  G. Sourvinos,et al.  Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. , 1998, Biochemical and biophysical research communications.

[36]  T. Zhukov,et al.  Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  Y. Houvras,et al.  Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl , 1997, Nature.

[38]  M. Fry,et al.  Sequence-specific Binding Protein of Single-stranded and Unimolecular Quadruplex Telomeric DNA from Rat Hepatocytes* , 1997, The Journal of Biological Chemistry.

[39]  B. Stillman,et al.  p53-induced p21 controls DNA replication. , 1997, Leukemia.

[40]  Z. Kelman.  PCNA: structure, functions and interactions , 1997, Oncogene.

[41]  S. Riva,et al.  The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[42]  J. Rossant,et al.  The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse , 1996, Cell.

[43]  J. Hurwitz,et al.  Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21 (*) , 1995, The Journal of Biological Chemistry.

[44]  W. Mercer,et al.  p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. , 1995, Cancer research.

[45]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[46]  S. Riva,et al.  Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter. , 1993, Journal of molecular biology.

[47]  P. Good,et al.  Three new members of the RNP protein family in Xenopus. , 1993, Nucleic acids research.

[48]  M. Clemens,et al.  The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. , 1992, Journal of cell science.

[49]  A. Bernstein,et al.  Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth , 1992, Molecular and cellular biology.

[50]  E. Appella,et al.  The p53 tumor suppressor protein, a modulator of cell proliferation. , 1992, The Journal of biological chemistry.

[51]  R. Scott,et al.  Loss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of heterogeneous ribonuclear proteins , 1989, The Journal of cell biology.

[52]  S. Riva,et al.  cDNA cloning of human hnRNP protein A1 reveals the existence of multiple mRNA isoforms. , 1988, Nucleic acids research.

[53]  G. Leser,et al.  Changes in heterogeneous nuclear RNP core polypeptide complements during the cell cycle , 1987, The Journal of cell biology.

[54]  M. Dorée,et al.  Protein kinase C: properties and possible role in cellular division and differentiation. , 1985, Biochimie.

[55]  R. Jones,et al.  HnRNP core proteins: Synthesis, turnover and intracellular distribution , 1979, Molecular Biology Reports.

[56]  J. Jami,et al.  Comparison of chromosomal proteins of mouse primitive teratocarcinoma, liver and L cells. , 1976, Experimental cell research.

[57]  濱崎 慎.  Expression of hnRNP B1 in four major histological types of lung cancers , 2003 .

[58]  F. Hucho,et al.  Identification of PSF as a protein kinase Cα‐binding protein in the cell nucleus , 2002, Journal of cellular biochemistry.

[59]  H. Müller-Hermelink,et al.  Deactivation of regulatory proteins hnRNP A1 and A2 during SC-1 induced apoptosis. , 2001, Human antibodies.

[60]  C. Ford.  Prospective Detection of Preclinical Lung Cancer : Results from Two Studies of Heterogeneous Nuclear Ribonucleoprotein A 2 / B 1 Overexpression , 2000 .

[61]  S. Segal,et al.  The role of protein kinase C in G1 and G2/M phases of the cell cycle (review). , 1998, International journal of oncology.

[62]  A. Treston,et al.  Purification and Characterization of a Protein That Permits Early Detection of Lung Cancer IDENTIFICATION OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN-A2/B1 AS THE ANTIGEN FOR MONOCLONAL ANTIBODY 703D4* , 1996 .

[63]  C. Burd,et al.  hnRNP proteins and the biogenesis of mRNA. , 1993, Annual review of biochemistry.

[64]  A. Beyer,et al.  The packaging proteins of core hnRNP particles and the maintenance of proliferative cell states. , 1978, Cold Spring Harbor symposia on quantitative biology.